Spin-off Philae Pharmaceuticals receives investment from Pharma Connect Capital
Wednesday 2 October 2019
- Life Cooperative
The Groningen-based investment fund Pharma Connect Capital today announced it has made an investment in Philae Pharmaceuticals, a dermatology spin-off company from the University Medical Center Groningen (UMCG). This investment will enable Philae Pharmaceuticals to start the development of targeted therapies for severe and difficult-to-treat dermatological diseases.
Working on a treatment for Butterfly Children
The initial disease Philae will focus on is Epidermolysis Bullosa (EB), a very rare but lethal disease for which currently no treatment or cure exists. Patients with EB are known as Butterfly Children because their skin is as vulnerable as the wings of a butterfly. Even the slightest contact or friction can easily tear or blister their skin.
About Philae Pharmaceuticals
Philae Pharmaceuticals (www.philae-pharma.com) is an initiative of late professor Marcel Jonkman, former chairman of the Dermatology Department of UMCG, emeritus chemistry professor Dick Kellogg and pharmacologist Dr. Reinier Schwietert.
About Pharma Connect Capital
Pharma Connect Capital (www.pharmaconnectcapital.com ) is an investment fund that finances early stage drug development. The fund is an initiative of Investerings Fonds Groningen, University Medical Center Groningen and the Noordelijke Ontwikkelings Maatschappij (NOM) and was launched in October 2017.
Focus areasLife Cooperative
Tuesday 14 January 2020
MercachemSyncom closes acquisition of Alcami Weert
Tuesday 7 January 2020
Polyganics Achieves CE Mark Certification for LIQOSEAL®
Tuesday 17 December 2019
Tell me about the North: Top Dutch Stories
Friday 4 October 2019
Groningen company CC Diagnostics wins 'Jonge Onderne..
Thursday 29 August 2019
CC Diagnostics final 'Jonge Ondernemingsprijs'
Wednesday 3 July 2019
Biomarkers in Groningen set the tone nationwide
Tuesday 7 May 2019
Ofinext first with production medicinal cannabis oil
Friday 26 April 2019
CC Diagnostics and EV Biotech nominated for most pioneerin..
Tuesday 16 April 2019
New building Polyganics on Zernike Campus
Wednesday 13 March 2019
Enthusiastic crowd Beta Business Days 2019